Molecular understanding of phase stability and transition of the amorphous state helps in formulation and manufacturing of poorly-soluble drugs. Crystallization of a model compound, 2-phenylamino nicotinic acid (2PNA), from the amorphous state was studied using solid-state analytical methods. Our previous report suggests that 2PNA molecules mainly develop intermolecular –COOH∙∙∙pyridine N (acid-pyridine) interactions in the amorphous state. In the current study, the molecular speciation is explored with regard to the phase transition from the amorphous to the crystalline state.
Using spectroscopic techniques, the molecular interactions and structural evolvement during the recrystallization from the glassy state were investigated.
The results unveiled that the structurally heterogeneous amorphous state contains acid-pyridine aggregates – either as hydrogen-bonded neutral molecules or as zwitterions – as well as a population of carboxylic acid dimers. Phase transition from the amorphous state results in crystal structures composed of carboxylic acid dimer (acid-acid) synthon or acid-pyridine chains depending on the crystallization conditions employed.
The study underlines the structural evolvement, as well as its impact on the metastability, of amorphous samples from local, supramolecular assemblies to long-range intermolecular ordering through crystallization.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
Janssens S, Van den Mooter G. Review: physical chemistry of solid dispersions. J Pharm Pharmacol. 2009;61:1571–86.
Konno H, Taylor LS. Influence of different polymers on the crystallization tendency of molecularly dispersed amorphous felodipine. J Pharm Sci. 2006;95:2692–705.
Chen J, Sarma B, Evans JM, Myerson AS. Pharmaceutical crystallization. Cryst Growth Des. 2011;11:887–95.
Davey RJ, Schroeder SL, ter Horst JH. Nucleation of organic crystals--a molecular perspective. Angew Chem Int Ed Engl. 2013;52:2166–79.
Davey RJ, Blagden N, Righini S, Alison H, Quayle MJ, Fuller S. Crystal polymorphism as a probe for molecular self-assembly during nucleation from solutions 2,6-dihydroxybenzoic acid. Cryst Growth Des. 2001;1:59–65.
Davey RJ, Dent G, Mughal RK, Parveen S. Concerning the relationship between structural and growth synthons in crystal nucleation- solution and crystal chemistry of carboxylic acids as revealed through ir spectroscopy. Cryst Growth Des. 2006;6:1788–96.
Apperley DC, Forster AH, Fournier R, Harris RK, Hodgkinson P, Lancaster RW, et al. Characterisation of indomethacin and nifedipine using variable-temperature solid-state nmr. Magn Reson Chem. 2005;43:881–92.
Taylor LS, Zografi G. Spectroscopic characterization of interactions between pvp and indomethacin in amorphous molecular dispersions. Pharm Res. 1997;14:1691–8.
Yaun X, Xiang T-X, Anderso BD, Munson EJ. Hydrogen bonding interactions in amorphous indomethacin and its amorphous solid dispersions with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl acetate) studied using 13c solid-state nmr. Mol Pharm. 2015;12:4518–28.
Andronis V, Zografi G. Crystal nucleation and growth of indomethacin polymorphs from the amorphous state. J Non-Cryst Solids. 2000;271:236–48.
Yoshioka M, Hancock BC, Zografi G. Crystallization of indomethacin from the amorphous state below and above its glass transition temperature. J Pharm Sci. 1994;83:1700–5.
Kalra A, Luner P, Taylor LS, Byrn SR, Li T. Gaining thermodynamic insight from distinct glass formation kinetics of structurally similar organic compounds. J Pharm Sci 2017.
Kalra A, Tishmack P, Lubach JW, Munson EJ, Taylor LS, Byrn SR, et al. Impact of supramolecular aggregation on the crystallization kinetics of organic compounds from the supercooled liquid state. Mol Pharm. 2017;14:2126–37.
Long SH, Parkin S, Siegler MA, Cammers A, Li TL. Polymorphism and phase behaviors of 2-(phenylamino)nicotinic acid. Cryst Growth Des. 2008;8:4006–13.
Dixon WT. Spinning-sideband-free and spinning-sideband-only nmr spectra in spinning samples. J Chem Phys. 1982;77:1800.
Fung BM, Khitrin AK, Ermolaev K. An improved broadband decoupling sequence for liquid crystals and solids. J Magn Reson. 2000;142:97–101.
Metz G, Wu X, Smith SO. Ramped-amplitude cross polarization in magic-angle-spinning nmr. J Magn Res. 1994;110:219–27.
Song Z, Antzutkin ON, Feng X, Levitt MH. Sideband suppression in magic-angle-spinning nmr by a sequence of 5 pi pulses. Solid State Nucl Magn Reson. 1993;2:143–6.
Simon S, Duran M, Dannenberg JJ. How does basis set superposition error change the potential surfaces for hydrogen bonded dimers? J Chem Phys. 1996;105:11024–31.
Ditchfie R. Self-consistent perturbation-theory of diamagnetism .1. Gauge-invariant lcao method for nmr chemical-shifts. Mol Phys. 1974;27:789–807.
Wolinski K, Hinton JF, Pulay P. Efficient implementation of the gauge-independent atomic orbital method for nmr chemical-shift calculations. J Am Chem Soc. 1990;112:8251–60.
Cheeseman JR, Trucks GW, Keith TA, Frisch MJ. A comparison of models for calculating nuclear magnetic resonance shielding tensors. J Chem Phys. 1996;104:5497–509.
Casabianca LB, De Dios AC. Ab initio calculations of nmr chemical shifts. J Chem Phys. 2008;128:10.
Bernstein J. Polymorphism in molecular crystals. New York: Oxford University Press. 2002;
Sundaraganesan N, Ilakiamani S, Saleem H, Wojciechowski PM, Michalska D. Ft-raman and ft-ir spectra, vibrational assignments and density functional studies of 5-bromo-2-nitropyridine. Spectrochim Acta A Mol Biomol Spectrosc. 2005;61:2995–3001.
Li ZJ, Abramov Y, Bordner J, Leonard J, Medek A, Trask AV. Solid-state acid-base interactions in complexes of heterocyclic bases with dicarboxylic acids: crystallography, hydrogen bond analysis, and 15n nmr spectroscopy. J Am Chem Soc. 2006;128:8199–210.
Song Y, Yang X, Chen X, Nie H, Byrn SR, Lubach JW. Investigation of drug–excipient interactions in lapatinib amorphous solid dispersions using solid-state nmr spectroscopy. Mol Pharm. 2015;12:857–66.
Babu NJ, Nangia A. Solubility advantage of amorphous drugs and pharmaceutical cocrystals. Cryst Growth Des. 2011;11:2662–79.
Milletti F, Storchi L, Sforna G, Cruciani G. New and original pka prediction method using grid molecular interaction fields. J Chem Inf Model. 2007;47:2172–81.
Kilburn D, Townrow S, Meunier V, Richardson R, Alam A, Ubbink J. Organization and mobility of water in amorphous and crystalline trehalose. Nat Mater. 2006;5:632–5.
Bates S, Zografi G, Engers D, Morris K, Crowley K, Newman A. Analysis of amorphous and nanocrystalline solids from their x-ray diffraction patterns. Pharm Res. 2006;23:2333–49.
Li T, Zhou P, Mattei A. Electronic origin of pyridinyl n as a better hydrogen-bonding acceptor than carbonyl o. CrystEngComm. 2011;13:6356–60.
ACKNOWLEDGMENTS AND DISCLOSURES
We thank CPD (Center for Pharmaceutical Development) and CPPR (Center for Pharmaceutical Processing Research) for providing partial financial support for this study. The authors declare the following competing financial interest(s): E.J.M. is a partial owner of Kansas Analytical Services, a company that provides solid-state NMR services to the pharmaceutical industry. The results presented here are from academic work at the University of Kentucky, and no data from Kansas Analytical Services are presented.
Guest Editors: Tony Zhou and Tonglei Li
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Kalra, A., Lubach, J.W., Munson, E.J. et al. Exploring Molecular Speciation and Crystallization Mechanism of Amorphous 2-Phenylamino Nicotinic Acid. Pharm Res 35, 51 (2018). https://doi.org/10.1007/s11095-018-2346-0
- intermolecular interactions
- molecular species
- phase transition
- solid-state NMR spectroscopy